Articles Tagged With: COVID-19
-
Waived Cost-Sharing Is Questionable Help to Hospitals
Hospitals may not charge patients with any type of insurance cost-sharing for COVID-19 testing and related services, according to the Families First Coronavirus Response Act. This will certainly help patients. For hospitals, it probably means more lost revenue.
-
CARES Act Offers Mix of Relief, Confusion for Struggling Hospitals
A $100 billion injection of relief funding for certain hospitals and other healthcare providers is just what the doctor ordered. However, for others, the money they will receive does not come close to addressing the shortfalls they are experiencing.
-
Social Media Use and Disordered Eating in Young Adolescents
The authors of this exploratory study in 996 young adolescents found an association between time spent on social media, number of social media accounts, and evidence of disordered eating behaviors.
-
Black Elderberry Supplementation for Upper Respiratory Infection Symptoms
SYNOPSIS: A meta-analysis of results from four randomized, controlled clinical studies evaluating the effect of black elderberry supplementation suggests that the botanical significantly reduces upper respiratory symptoms due to common cold and influenza viruses.
-
Shortcuts in Clinical Trials May Cause More Harm Than Good
Dozens of potential treatments for COVID-19 are under investigation: existing antiretrovirals, anti-malaria drugs, monoclonal antibodies, and Chinese traditional medicines among them. Additionally, companies are rapidly developing new drugs. But poorly designed studies subject patients to the risks of adverse events without learning if the intervention works.
-
Second Phase of Pandemic Raises More Questions, Concerns for IRBs
Research organizations and IRBs continue to face challenges and make tough decisions based on the best available information about a pandemic that changes daily as it spreads across the world.
-
What Happens to Human Research in the New Pandemic Era?
The big question in the clinical research world is how things will look when the COVID-19 pandemic has ended. Will everything go back to the way it was? If not, what changes will remain?
-
Federal Agencies, Pharma Industry Work to Speed COVID-19 Therapeutics, Vaccine
Public-private partnership aims to streamline, coordinate large-scale efforts.
-
The Role of Surgeons in the COVID-19 Era
Accrediting body helps surgery leaders find the right path forward during unusual times.
-
COVID-19 and Children
In China, children of all ages have been infected with SARS-CoV-2 and seem to follow a relatively mild clinical course.